Pharmafile Logo
Pharmafocus logo
Advanced Search

MSD

Showing 15 posts of 247 posts found.

merckwindowweb

MSD’s interim Keytruda combo data spooks Roche and BMS

January 16, 2018
Research and Development MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical

When PD-1/L1 treatments first came on the market, there was a race to snaffle as many indications as possible for …

News
fda2outsideweb

AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer

January 15, 2018
Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma

The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …

News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …

News
merck_and_co

MSD and Pfizer receive approval for combo diabetes therapy

December 21, 2017
Sales and Marketing MSD, Pfizer, biotech, diabetes, drugs, pharma, pharmaceutical

MSD (known as Merck in North America) and Pfizer have announced that their sodium-glucose co-transporter 2 (SGLT2) inhibitor has received …

News
merckwindowweb

Keytruda falls hard at gastric cancer hurdle

December 18, 2017
Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

There was a time when PD-1/L1 immunotherapy treatments could do no wrong, blasting through indication after indication. However, the limits …

News
houses-of-parliament-1055056_960_720

UK government unveils pharma research HQ coup

November 27, 2017
Medical Communications, Sales and Marketing MSD, biotech, drugs, life sciences, pharma, pharmaceutical

The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …

News

MSD withdraws European application of Keytruda combo in lung cancer

October 30, 2017
Sales and Marketing EMA, MSD, keytruda

MSD has been forced to withdraw its EU marketing application for Keytruda (pembrolizumab) in combination with pemetrexed and carboplatin as …

News
merckentranceweb

Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

October 30, 2017
Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …

News

MSD cuts 1,800 jobs in US operations restructure

October 23, 2017
Manufacturing and Production, Sales and Marketing MSD, Merck, job cuts, pharma

MSD has revealed its intention to cut 1,800 sales positions from its workforce in the US. Across the total number, …

News
merckwindowweb

MSD gives up on cholesterol drug, despite positive results

October 12, 2017
Medical Communications, Sales and Marketing MSD, Merck, biotech, cholesterol, drugs, pharma, pharmaceutical

MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …

News
merck_incweb

MSD pulls out of hep C space to Gilead’s relief

October 2, 2017
Sales and Marketing MSD, biotech, drugs, hepatitis C, pharma, pharmaceutical

MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in …

News
merckwindowweb

MSD plays catch up with €464m deal for fledgling biotech

September 7, 2017
Sales and Marketing Bristol-Myers Squibb, MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD has announced that it will acquire Rigontec, a three-year old German biotech, in a deal worth an initial €115 …

News
virginia-7592

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Feature
pharmafocus_september_2017_cover

The September 2017 issue of Pharmafocus is now live!

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.

News
merckincweb

MSD scores trial success in reducing cardiovascular risk

August 29, 2017
Manufacturing and Production, Research and Development MSD, heart attack, heart disease, life sciences, pharma, pharmaceutical

New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025